Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: A case-control study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
28
04
2023
accepted:
11
11
2023
medline:
1
12
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Multidrug-resistant Tuberculosis (MDR-TB) remains a global health concern. The disease results in a prolonged treatment and hence, poses a financial burden to affected individuals and their families. The Ghana National TB Control Programme (NTP) has made extensive efforts to control the menace, however, it remains a concern. This study, therefore, aimed to determine the predictors of multidrug-resistant TB in the Cape Coast Teaching Hospital of Ghana. An unmatched case-control study involving 37 cases and 111 controls was conducted using data of TB cases registered for treatment between January 2018 and December 2020 at the Cape Coast Teaching Hospital. Socio-demographic, individual level and social characteristics information were collected from respondents through telephone surveys, face-to-face interviews and review of records using a structured questionnaire built in the Kobo Collect Toolbox. The data was exported to Stata version 16.0 for analysis. Chi-square test and multiple logistic regression were used to determine the predictors of MDR-TB. Associations were considered statistically significant at a 95% confidence interval with a p-value of less than 0.05. The results revealed that the majority (25 [67.6%]) of MDR-TB cases and controls (76 [68.5%]) were aged 30 years and above with a median age of 36.5 (IQR: 28-50) years for all respondents, while 20 (54.1%) of MDR-TB cases and 33 (29.7%) of controls lived in households with one room residences for their families. The following predictors for MDR-TB were identified: BCG vaccination status (AOR = 0.17,95% CI:0.07-0.45), long distance to health facility (AOR = 4.11, 95% CI: 1.55-10.87), number of rooms in residence (AOR = 0.37,95% CI: 0.14-0.99) and first place of visit upon noticing TB symptom (AOR = 4.22,95% CI:1.31-13.64). Predictors of MDR-TB in the current study were multi-faceted. Measures to control MDR-TB should target socio-demographic, health-seeking behaviour and social-related concerns.
Identifiants
pubmed: 38019801
doi: 10.1371/journal.pone.0294928
pii: PONE-D-23-11560
pmc: PMC10686500
doi:
Substances chimiques
Antitubercular Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0294928Informations de copyright
Copyright: © 2023 Afful et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exists.
Références
PLoS One. 2022 Jul 5;17(7):e0270819
pubmed: 35789216
Ann Clin Microbiol Antimicrob. 2018 Jul 3;17(1):30
pubmed: 29970076
PLoS One. 2018 Jun 4;13(6):e0197737
pubmed: 29864118
Medicine (Baltimore). 2020 Jul 24;99(30):e21296
pubmed: 32791713
BMC Public Health. 2013 Aug 28;13:782
pubmed: 23981845
PLoS One. 2016 Mar 09;11(3):e0150849
pubmed: 26959366
Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863
pubmed: 25918181
Antimicrob Resist Infect Control. 2019 May 2;8:70
pubmed: 31073401
Sci Rep. 2022 Jan 14;12(1):745
pubmed: 35031658
PLoS One. 2021 Jun 10;16(6):e0252819
pubmed: 34111159
BMC Infect Dis. 2018 May 31;18(1):249
pubmed: 29855354
Pan Afr Med J. 2014 Jan 31;17:78
pubmed: 24711884
Lancet. 2005 Oct 22-28;366(9495):1443-51
pubmed: 16243089
BMJ Open. 2022 Jul 5;12(7):e062857
pubmed: 35790328
Infect Drug Resist. 2017 Mar 13;10:91-96
pubmed: 28331350
Public Health Action. 2022 Jun 21;12(2):79-84
pubmed: 35734012
PLoS One. 2022 Jun 16;17(6):e0270003
pubmed: 35709161
Clin Infect Dis. 2008 Jun 15;46(12):1844-51
pubmed: 18462099
BMC Health Serv Res. 2021 Oct 1;21(1):1033
pubmed: 34592970
SAGE Open Med. 2021 Jan 30;9:2050312121989497
pubmed: 33614034
Int J Mycobacteriol. 2012 Sep;1(3):137-42
pubmed: 26787209
Afr J Prim Health Care Fam Med. 2020 May 26;12(1):e1-e10
pubmed: 32501027
BMC Infect Dis. 2017 Sep 29;17(1):655
pubmed: 28962599